
1. nature. 2012 jul 26;487(7408):491-5. doi: 10.1038/nature11288.

interpreting cancer genomes using systematic host network perturbations tumour
virus proteins.

rozenblatt-rosen o(1), deo rc, padi m, adelmant g, calderwood ma, rolland t,
grace m, dricot a, askenazi m, tavares m, pevzner sj, abderazzaq f, byrdsong d,
carvunis ar, chen aa, cheng j, correll m, duarte m, fan c, feltkamp mc, ficarro
sb, franchi r, garg bk, gulbahce n, hao t, holthaus am, james r, korkhin a,
litovchick l, mar jc, pak tr, rabello s, rubio r, shen y, singh s, spangle jm,
tasan m, wanamaker s, webber jt, roecklein-canfield j, johannsen e, barabási al, 
beroukhim r, kieff e, cusick me, hill de, münger k, marto ja, quackenbush j, roth
fp, decaprio ja, vidal m.

author information: 
(1)genomic analysis network perturbations center excellence genomic
science, dana-farber cancer institute, boston, massachusetts 02215, usa.

comment in
    nat rev cancer. 2012 sep;12(9):582.
    nat methods. 2012 sep;9(9):868.

genotypic differences greatly influence susceptibility resistance disease.
understanding genotype-phenotype relationships requires phenotypes viewed
as manifestations network properties, rather simply result of
individual genomic variations. genome sequencing efforts identified numerous
germline mutations, large numbers somatic genomic alterations, associated 
with predisposition cancer. however, remains difficult distinguish
background, 'passenger', cancer mutations causal, 'driver', mutations 
in data sets. human viruses intrinsically depend host cell 
the course infection elicit pathological phenotypes similar those
arising mutations. test hypothesis genomic variations and
tumour viruses may cause cancer related mechanisms, systematically
examining host interactome transcriptome network perturbations caused dna 
tumour virus proteins. resulting integrated viral perturbation data reflects 
rewiring host cell networks, highlights pathways, notch
signalling apoptosis, go awry cancer. show systematic
analyses host targets viral proteins identify cancer genes a
success rate par identification functional genomics and
large-scale cataloguing tumour mutations. together, complementary
approaches increase specificity cancer gene identification. combining
systems-level studies pathogen-encoded gene products genomic approaches
will facilitate prioritization cancer-causing driver genes advance 
understanding genetic basis human cancer.

doi: 10.1038/nature11288 
pmcid: pmc3408847
pmid: 22810586  [indexed medline]

